2,2-bis(4-glycidyloxyphenyl)propane has been researched along with 1-methyl-3-isobutylxanthine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clish, CB; Hauser, S; Hiramatsu, R; Mikami, T; Serhan, CN; Spiegelman, BM; Wright, HM; Yanagi, K | 1 |
1 other study(ies) available for 2,2-bis(4-glycidyloxyphenyl)propane and 1-methyl-3-isobutylxanthine
| Article | Year |
|---|---|
A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation.
Topics: 1-Methyl-3-isobutylxanthine; 3T3 Cells; Adipocytes; Animals; Benzhydryl Compounds; Cell Differentiation; Cell Nucleus; Chromatography, High Pressure Liquid; Dexamethasone; Dose-Response Relationship, Drug; Epoxy Compounds; Gas Chromatography-Mass Spectrometry; Glucocorticoids; Hypoglycemic Agents; Insulin; Ligands; Mice; Phosphodiesterase Inhibitors; Protein Binding; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic | 2000 |